Sagar Mungekar
Faculty Peer Reviewed
The incidence of male pattern hair loss can reach almost 100% in some ethnic groups.1, 2 While treatment of the condition is usually deferred to …
Category: Endocrine
Clinical Correlations
Continuous Glucose Monitors
December 2, 2009
Ilena George
Faculty peer reviewed
Are continuous glucose monitors the answer for better glucose control in diabetes?
A poorly controlled type 2 diabetic who is non-compliant with his at-home glucose monitoring comes to Bellevue’s Adult Primary Care …
What is the Role of Drug Therapy in Treating Obesity?
November 19, 2009
Arlene Chung
Faculty Peer Reviewed
Despite the high prevalence of obesity1 and its associated morbidity2 and mortality 3,4, it represents one of the most difficult chronic conditions to treat. Barriers include a …
Breaking News: FDA issues new warning for Exenatide (Byetta®)
November 5, 2009
Kanika Ballani, Pharm.D.
Diana Hubulasvili, Pharm.D.
Developed by Amylin Pharmaceuticals, Exenatide (Byetta®) is an incretin mimetic that is used as an adjunctive therapy with metformin, a sulfonylurea or a thiazolidinedione to improve glycemic …
The Utility of GlycoMark ™: 1,5 Anhydroglucitol as a Marker for Glycemic Control
September 16, 2009
David R. Friedmann MD
Faculty Peer Reviewed
Hemoglobin A1 (Hb A1c) is the standard method for monitoring diabetic patients’ long-term glycemic control by indicating average blood glucose levels over a …
Grand Rounds: Primary Aldosteronism, Beyond Conn’s Syndrome
June 4, 2009
Michael Chu MD
Please also see the clinical vignette presented before Grand Rounds on the 21st of May.
The Medical Grand Rounds presentation on May …
Deciphering Fact from Fiction in Hypoglycemia
March 26, 2009
Commentary by Melissa Price, MD PGY3
Faculty Peer Reviewed
A 42 year-old male phlebotomist with a history of anxiety presented to the emergency room complaining of four hours of dizziness and diaphoresis. He …
Class Act: AGE-RAGE: What we know about the pathophysiology of diabetic neuropathy.
December 26, 2008
Commentary by Regina Mysliwiec, NYU Medical Student
Faculty Peer Reviewed
G.L. is a 62 year-old African-American male with a six year history of Type 2 Diabetes with variable glucose control and a progressive …